Moderna Stock Analysis

MRNA
 Stock
  

USD 122.23  2.54  2.12%   

Moderna price slip over the last few months may encourage investors to take a closer look at the firm as it is trading at a share price of 122.23 on 3,793,914 in trading volume. The company management teams were not very successful in positioning the firm resources to exploit market volatility in August. However, diversifying your holdings with Moderna or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.96. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Moderna partners.
Additionally, see Correlation Analysis.
  
The Moderna stock analysis report makes it easy to digest most publicly released information about Moderna and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Moderna Stock analysis module also helps to analyze the Moderna price relationship with some important fundamental indicators such as market cap and management efficiency.

Moderna Stock Analysis Notes

About 64.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.96. Moderna had not issued any dividends in recent years. The entity had 1:10 split on the 3rd of August 2017. Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. Moderna operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3200 people. To find out more about Moderna contact Michael French at 617 714 6500 or learn more at https://www.modernatx.com.

Moderna Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Moderna's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Moderna or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Moderna generated a negative expected return over the last 90 days
Moderna has high historical volatility and very poor performance
About 64.0% of the company shares are owned by institutional investors
Latest headline from www.nasdaq.com: Down 85, Is There Any Hope for This Struggling Vaccine Stock - Nasdaq

Moderna Upcoming and Recent Events

Earnings reports are used by Moderna to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Moderna previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report24th of February 2022
Next Financial Report5th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End24th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Moderna SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Moderna prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Moderna investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Moderna specific information freely available to individual and institutional investors to make a timely investment decision.
17th of August 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
3rd of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
1st of June 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
24th of May 2022
Financial Statements and Exhibits. Regulation FD Disclosure
View
13th of May 2022
Financial Statements and Exhibits. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
11th of May 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
4th of May 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
3rd of May 2022
Submission of Matters to a Vote of Security Holders
View

Moderna Thematic Classifications

In addition to having Moderna stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Biotech
Biotechnology and pharmaceuticals production and services

Moderna Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Moderna is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Moderna backward and forwards among themselves. Moderna's institutional investor refers to the entity that pools money to purchase Moderna's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Baillie Gifford CoCommon Shares45.6 M6.5 B
Vanguard Group IncCommon Shares27.6 M3.9 B
Blackrock IncCommon Shares26.2 M3.7 B
State Street CorpCommon Shares14.8 M2.1 B
Flagship Pioneering IncCommon Shares12.9 M1.8 B
Theleme Partners LlpCommon Shares6.4 M907.7 M
Geode Capital Management LlcCommon Shares6.3 M904.1 M
Susquehanna International Group LlpCall Options2.5 M356.6 M
Note, although Moderna's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Moderna Market Capitalization

The company currently falls under 'Large-Cap' category with current market capitalization of 50.13 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Moderna's market, we take the total number of its shares issued and multiply it by Moderna's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Moderna Profitablity

Moderna's profitability indicators refer to fundamental financial ratios that showcase Moderna's ability to generate income relative to its revenue or operating costs. If, let's say, Moderna is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Moderna's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Moderna's profitability requires more research than a typical breakdown of Moderna's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 64.77 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 73.24 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.73.

Management Efficiency

The entity has return on total asset (ROA) of 50.42 % which means that it generated profit of $50.42 on every $100 spent on asset. This is very large. Similarly, it shows return on stockholders equity (ROE) of 139.99 %, meaning that it created $139.99 on every $100 dollars invested by stockholders. Moderna management efficiency ratios could be used to measure how well moderna manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 27th of September, Moderna secures the mean deviation of 2.81, and Risk Adjusted Performance of (0.05). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Moderna, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Moderna, which can be compared to its peers in the industry. Please verify Moderna coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Moderna is priced some-what accurately, providing market reflects its recent price of 122.23 per share. Given that Moderna has jensen alpha of (0.09), we recommend you to check Moderna's last-minute market performance to make sure the company can sustain itself at a future point.

Moderna Price Movement Analysis

The output start index for this execution was thirty-four with a total number of output elements of twenty-seven. The Weighted Moving Average calculates a weight for each value in Moderna price series with the more recent values given greater weights.
.

Moderna Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Moderna insiders, such as employees or executives, is commonly permitted as long as it does not rely on Moderna's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Moderna insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Bancel Stephane few days ago via Macroaxis 
Exercise or conversion by Bancel Stephane of 40000 shares of Moderna subject to Rule 16b-3
Bancel Stephane over a week ago via Macroaxis 
Exercise or conversion by Bancel Stephane of 40000 shares of Moderna subject to Rule 16b-3
Klinger Shannon Thyme over two weeks ago via Macroaxis 
Exercise or conversion by Klinger Shannon Thyme of 1138 shares of Moderna subject to Rule 16b-3
Bancel Stephane over three weeks ago via Macroaxis 
Exercise or conversion by Bancel Stephane of 40000 shares of Moderna subject to Rule 16b-3
Bancel Stephane over a month ago via Macroaxis 
Exercise or conversion by Bancel Stephane of 40000 shares of Moderna subject to Rule 16b-3
Hoge Stephen over a month ago via Macroaxis 
Exercise or conversion by Hoge Stephen of 5000 shares of Moderna subject to Rule 16b-3
Bancel Stephane over a month ago via Macroaxis 
Sale by Bancel Stephane of 23418 shares of Moderna
Hoge Stephen over a month ago via Macroaxis 
Exercise or conversion by Hoge Stephen of 5000 shares of Moderna subject to Rule 16b-3
Andres Juan over a month ago via Macroaxis 
Exercise or conversion by Andres Juan of 2000 shares of Moderna subject to Rule 16b-3
Burton Paul over a month ago via Macroaxis 
Exercise or conversion by Burton Paul of 1609 shares of Moderna subject to Rule 16b-3
Andres Juan over a month ago via Macroaxis 
Exercise or conversion by Andres Juan of 2000 shares of Moderna subject to Rule 16b-3
Bancel Stephane over a month ago via Macroaxis 
Exercise or conversion by Bancel Stephane of 40000 shares of Moderna subject to Rule 16b-3

Moderna Predictive Daily Indicators

Moderna intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Moderna stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Moderna Forecast Models

Moderna time-series forecasting models is one of many Moderna's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Moderna's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Moderna Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Moderna prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Moderna shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Moderna. By using and applying Moderna Stock analysis, traders can create a robust methodology for identifying Moderna entry and exit points for their positions.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. Moderna operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3200 people.

Current Moderna Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Moderna analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Moderna analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
257.23Hold13Odds
Moderna current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Moderna analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Moderna stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Moderna, talking to its executives and customers, or listening to Moderna conference calls.
Moderna Analyst Advice Details

Moderna Stock Analysis Indicators

Moderna stock analysis indicators help investors evaluate how Moderna stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Moderna shares will generate the highest return on investment. By understating and applying Moderna stock analysis, traders can identify Moderna position entry and exit signals to maximize returns.
Quick Ratio1.46
Fifty Two Week Low115.61
Revenue Growth213.20%
Average Daily Volume Last 10 Day5.9M
Shares Short Prior Month14.76M
Average Daily Volume In Three Month4.93M
Earnings Growth202.10%
Shares Percent Shares Out4.09%
Earnings Quarterly Growth199.50%
Gross Margins75.29%
Forward Price Earnings14.28
Short Percent Of Float5.49%
Float Shares360.03M
Fifty Two Week High453.61
Fifty Day Average153.07
Enterprise Value To Ebitda3.39
Two Hundred Day Average165.40
Enterprise Value To Revenue2.48
Additionally, see Correlation Analysis. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for analysis

When running Moderna price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine Moderna value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.